(Q45740412)

15 December 2017

Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases (English)

1 reference

15 December 2017

1 reference

1

1 reference

15 December 2017

G Zahuczky

2

1 reference

15 December 2017

P Bagossi

3

1 reference

15 December 2017

J M Louis

4

1 reference

15 December 2017

T D Copeland

5

1 reference

15 December 2017

S Oroszlan

6

1 reference

15 December 2017

R W Harrison

7

1 reference

15 December 2017

I T Weber

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

15 December 2017

1 reference

15 December 2017

267

1 reference

15 December 2017

20

1 reference

15 December 2017

6287-6295

1 reference

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

15 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

21 January 2018

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Substrates and inhibitors of human T-cell leukemia virus type I protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Structure-based inhibitors of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Inhibitors of HIV-1 protease: a major success of structure-assisted drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Structural basis for specificity of retroviral proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Analysis of six protein structures predicted by comparative modeling techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Studies on the role of the S4 substrate binding site of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Molecular model of equine infectious anemia virus proteinase and kinetic measurements for peptide substrates with single amino acid substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Solid phase synthesis of the proteinase of bovine leukemia virus. Comparison of its specificity to that of HIV-2 proteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Specificity studies on retroviral proteinase from myeloblastosis-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Evaluation of homology modeling of HIV protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Specificity of Retroviral Proteinases Based on Substrates Containing Tyrosine and Proline at the Site of Cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01714.X

10.1046/J.1432-1327.2000.01714.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference